B CELL LYMPHOMA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
EARLY CANCER;
HUMAN;
LARGE CELL LYMPHOMA;
LETTER;
NONHODGKIN LYMPHOMA;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
RADIOIMMUNOTHERAPY;
RISK FACTOR;
SURVIVAL TIME;
UNSPECIFIED SIDE EFFECT;
New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project
Armitage J., and Weisenburger D. New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 16 (1998) 2780-2795
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma
Coiffier B., Lepage E., Briere J., et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346 (2002) 235-242
Long term results of the GELA study, R-CHOP vs. CHOP in elderly patients with diffuse large B-cell lymphoma
abstr 1383
Coiffier B., Feugier P., Sebban C., et al. Long term results of the GELA study, R-CHOP vs. CHOP in elderly patients with diffuse large B-cell lymphoma. Blood 104 (2004) abstr 1383
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MinT) Group
Pfreundschuh M., Trumper L., Osterborg A., et al. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MinT) Group. Lancet Oncol 7 (2006) 379-391
Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma
Miller T., Dahlberg S., Cassady J., et al. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med 339 (1998) 21-26
CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial
(abstr)
Miller T., LeBlanc M., Spier C., et al. CHOP alone compared to CHOP plus radiotherapy for early stage aggressive non-Hodgkin's lymphomas: update of the Southwest Oncology Group (SWOG) randomized trial. Blood 98 (2001) 724-725 (abstr)
Effect of adding rituximab to three cycles of CHOP plus involved field radiotherapy for limited-stage aggressive diffuse B cell lymphoma, SWOG 0014
abstr 158
Miller T., Unger J., Spier C., et al. Effect of adding rituximab to three cycles of CHOP plus involved field radiotherapy for limited-stage aggressive diffuse B cell lymphoma, SWOG 0014. Blood 104 (2004) abstr 158